| Literature DB >> 30611197 |
Silvia Loggi1, Nicoletta Mininno1, Elisa Damiani1, Benedetto Marini1, Erica Adrario1, Claudia Scorcella1, Roberta Domizi1, Andrea Carsetti1, Simona Pantanetti1, Gabriele Pagliariccio2, Luciano Carbonari2, Abele Donati3.
Abstract
BACKGROUND: In vascular surgery with aortic cross-clamping, ischemia/reperfusion injury induces systemic haemodynamic and microcirculatory disturbances. Different anaesthetic regimens may have a varying impact on tissue perfusion. The aim of this study was to explore changes in microvascular perfusion in patients undergoing elective open abdominal aortic aneurysm repair under balanced or total intravenous anaesthesia.Entities:
Keywords: Anaesthesia; Aortic surgery; Haemodynamics; Ischemia/reperfusion injury; Microcirculation
Mesh:
Substances:
Year: 2019 PMID: 30611197 PMCID: PMC6320625 DOI: 10.1186/s12871-018-0673-7
Source DB: PubMed Journal: BMC Anesthesiol ISSN: 1471-2253 Impact factor: 2.217
Fig. 1Study flow diagram
General and intraoperative data for the two groups of patients receiving balanced anaesthesia or total intravenous anaesthesia
| Balanced anaesthesia | TIVA |
| |
|---|---|---|---|
| Age (years) | 75 ± 7 | 74 ± 6 | 0.464 |
| Gender (nr, % of males) | 16, 80% | 18, 90% | 0.376 |
| ASA score (nr, %) | 0.127 | ||
| | 13, 65% | 18, 90% | |
| | 7, 35% | 2, 10% | |
| Comorbidities (nr, %) | |||
| | 20, 100% | 18, 90% | 0.149 |
| | 6, 30% | 10, 50% | 0.197 |
| | 3, 15% | 5, 25% | 0.429 |
| | 12, 60% | 8, 40% | 0.206 |
| | 10, 50% | 10, 50% | 0.999 |
| | 10, 50% | 8, 40% | 0.525 |
| Clamping time (min) | 65 ± 29 | 69 ± 31 | 0.691 |
| Fluid balance (ml) | −200 [− 1100 − + 150] | − 195 [−670 − + 300] | 0.657 |
| Norepinephrine | |||
| | 20, 100% | 20, 100% | 0.999 |
| | 0.15 [0.08–0.20] | 0.12 [0.09–0.15] | 0.466 |
| Dobutamine | |||
| | 13, 65% | 16, 80% | 0.288 |
| | 2.00 [1.23–3.00] | 2.39 [1.67–3.92] | 0.416 |
| Esmolol (nr, %) | 14, 70% | 10, 50% | 0.197 |
| Levosimendan (nr, %) | 3, 15% | 5, 25% | 0.429 |
| Blood transfusions | |||
| | 10, 50% | 10, 50% | 0.999 |
| | 540 [450–1060] | 580 [450–780] | 0.837 |
Data are expressed as mean ± standard deviation or median [1st-3rd quartile], as appropriate
Cardiopathy was defined by the presence of echocardiographic alterations including left ventricular hypertrophy and valvulopathy, or a history of coronary artery disease and/or heart failure and reduced left ventricular ejection fraction. Renal failure was defined by the presence of an estimated glomerular filtration rate lower than 60 ml/min/1.73mq
TIVA total intravenous anaesthesia, ASA American Society of Anesthesiology, COPD chronic obstructive pulmonary disease
Changes in haemodynamics and blood gases from baseline to end-surgery in the two groups of patients receiving balanced anaesthesia or total intravenous anaesthesia
| Balanced anaesthesia | TIVA | p for interaction (2-way ANOVA) | |||
|---|---|---|---|---|---|
| baseline | end-surgery | baseline | end-surgery | ||
| MAP (mmHg) | 94 ± 18 | 86 ± 13* | 92 ± 14 | 81 ± 12** | 0.642 |
| HR (bpm) | 67 ± 13 | 71 ± 11 | 70 ± 13 | 71 ± 14 | 0.521 |
| CI (ml/m2/min) | 2.4 ± 0.7 | 3.2 ± 0.6*** | 2.6 ± 0.5 | 2.8 ± 0.7 | 0.005 |
| SVRI (dyn*s*cm− 5) | 2800 [2352–3224] | 1839 [1691–2085]*** | 2488 [2203–2952] | 2119 [1754–2350]*** | – |
| pH | 7.42 [7.39–7.47] | 7.40 [7.38–7.43] | 7.43 [7.42–7.44] | 7.41 [7.37–7.45] | – |
| PaO2 (mmHg) | 70 [62–88] | 159 [145–207]** | 72 [63–166] | 194 [134–235]*** | – |
| PaCO2 (mmHg) | 38 ± 4 | 38 ± 4 | 37 ± 3 | 39 ± 5* | 0.027 |
| Base excess (mEq/l) | 0.5 [−0.3, + 2.5] | − 0.4 [− 3.2, + 1.2]** | 0.5 [− 1.4, + 1.2] | − 0.4 [− 1.9, + 2.4] | – |
| ScvO2 (%) | 72 [69–78] | 90 [82–92]*** | 79 [70–90]# | 91 [86–94]** | – |
| Lactate (mmol/l) | 0.6 [0.6–0.8] | 1.3 [1.1–1.9]*** | 0.7 [0.6–1.0] | 1.3 [1.0–1.5]*** | – |
| Hb (g/dl) | 13.3 ± 2.0 | 11.8 ± 0.8*** | 13.4 ± 1.6 | 11.8 ± 1.3*** | 0.793 |
| Glucose (mg/dl) | 96 [86–107] | 121 [105–131]*** | 102 [95–112] | 125 [106–141]*** | – |
*p < 0.05 **p < 0.01 ***p < 0.001 versus baseline, #p < 0.05 versus time-matched balanced anaesthesia. Two-way Analysis of Variance (ANOVA) with Sidack’s multiple comparisons test or Wilcoxon and Mann-Whitney U test, as appropriate. Data are expressed as mean ± standard deviation or median [1st-3rd quartile], as appropriate. TIVA total intravenous anaesthesia, MAP mean arterial pressure, HR heart rate, CI cardiac index, SVRI systemic vascular resistance index, PaO arterial oxygen tension, PaCO arterial carbon dioxide tension, ScvO central venous oxygen saturation, Hb haemoglobin
Changes in sublingual microcirculation and NIRS-derived parameters from baseline to end-surgery in the two groups of patients receiving balanced anaesthesia or total intravenous anaesthesia
| Balanced anaesthesia | TIVA | p for interaction (2-way ANOVA) | |||
|---|---|---|---|---|---|
| Baseline | end-surgery | baseline | end-surgery | ||
| MFI (small vessels) [AU] | 2.67 [2.50–2.75] | 2.83 [2.37–2.98] | 2.75 [2.58–2.90] | 2.67 [2.42–2.81] | – |
| Abnormal MFIa (n, %) | 9, 45% | 6, 30% | 7, 35% | 9, 45% | – |
| FHI [AU] | 0.15 [0.00–0.29] | 0.18 [0.02–0.36] | 0.23 [0.09–0.28] | 0.19 [0.10–0.38] | – |
| TVD (small) (mm/mm2) | 18.4 ± 3.8 | 21.0 ± 4.7* | 19.8 ± 4.0 | 20.7 ± 4.5 | 0.216 |
| TVD (medium) (mm/mm2) | 1.5 [0.9–2.2] | 1.2 [1.1–1.5] | 0.8 [0.6–1.1]## | 0.5 [0.1–0.8]### | – |
| PVD (small) (mm/mm2) | 16.6 ± 4.2 | 19.1 ± 5.4* | 18.1 ± 4.2 | 19.2 ± 4.9 | 0.302 |
| PVD (medium) (mm/mm2) | 1.5 [0.9–2.2] | 1.2 [1.1–1.5] | 0.8 [0.6–1.1]## | 0.5 [0.1–0.8]### | – |
| PPV (small, %) | 91 [83–97] | 91 [82–97] | 96 [83–98] | 95 [90–97] | – |
| StO2 (%) | 83 ± 5 | 86 ± 7 | 82 ± 6 | 85 ± 9 | 0.975 |
| StO2 Downslope 1 (%/min) | −8.0 [−10.8, −6.8] | −7.8 [− 10.4, − 6.9] | − 8.8 [− 12.0, − 7.8] | −8.1 [− 11.1, − 5.9]** | – |
| StO2 Downslope 2 (%/min) | −8.2 ± 3.3 | − 8.0 ± 4.8 | −8.2 ± 2.8 | − 8.0 ± 3.4 | 0.962 |
| Delta Downslope (2–1) (%/min) | 1.1 [− 0.5, 2.4] | −0.1 [− 1.6, 1.8] | 0.9 [− 0.8, 3.9] | −0.7 [− 1.4, 1.0] | – |
| StO2 Upslope (%/min) | 226 ± 64 | 206 ± 103 | 264 ± 84 | 247 ± 77 | 0.900 |
| AUC StO2 (%*min) | 14.8 ± 8.1 | 25.6 ± 14.8* | 20.4 ± 6.0 | 26.1 ± 19.1 | 0.359 |
| THI [AU] | 15.2 ± 2.0 | 15.3 ± 3.1 | 14.6 ± 3.3 | 12.8 ± 3.6# | 0.140 |
*p < 0.05 **p < 0.01 versus baseline, #p < 0.05 ##p < 0.01 ###p < 0.001 versus time-matched balanced anesthesia. Two-way Analysis of Variance (ANOVA) with Sidack’s multiple comparisons test or Wilcoxon and Mann-Whitney U test, as appropriate. Data are expressed as mean ± standard deviation or median [1st-3rd quartile], as appropriate
aAn abnormal MFI was defined as an MFI lower than 2.6 [25]
NIRS near infrared spectroscopy, TIVA total intravenous anaesthesia, MFI microvascular flow index, AU arbitrary unit, FHI flow heterogeneity index, TVD total vessel density, PVD perfused vessel density, PPV percentage of perfused vessels, StO tissue oxygen saturation, AUC StO area under the curve of StO2, THI tissue haemoglobin index
Fig. 2Changes in sublingual microvascular parameters from baseline to end-surgery in the two groups of patients receiving balanced anaesthesia or total intravenous anaesthesia (TIVA)
Fig. 3Changes in NIRS-derived parameters from baseline to end-surgery in the two groups of patients receiving balanced anaesthesia or total intravenous anaesthesia (TIVA). StO tissue oxygen saturation, AUC StO area under the curve of StO2 (area of hyperaemia)
Fig. 4Changes in the tissue haemoglobin index (THI) from baseline to end-surgery in the two groups of patients receiving balanced anaesthesia or total intravenous anaesthesia (TIVA)